Internal Medicine

On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.

Corticosteroid Injections and UV Light Effective in Vitiligo Management

October 15, 2021

Article

Investigators call the combination of intralesional corticosteroid injections and narrow-band ultraviolet B light to be “effective, simple, and relatively safe”.

Abatacept Ineffective in Prevention of Psoriasis Relapse

October 14, 2021

Article

Data from the PAUSE clinical trial reveals that more participants experienced psoriasis relapse in the abatacept group than the ustekinumab group.

Biden Administration Considering Califf as FDA Head

October 14, 2021

Article

Dr. Robert Califf previously ran the FDA in 2016 and 2017 under former President Barack Obama.

Pursuing Tailored Care for Diabetic Macular Edema

October 13, 2021

Video

The retina field is equipped with ideal therapy and research informing implementation. Now it needs greater patient buy-in.

Intravitreal Injections Linked to Psychosocial Burden in Retina Disease Patients

October 13, 2021

Article

Assessment from a patient survey showed an association between increased rates of injection treatment and increased restriction on usual activity for patients.

Factors Influencing Treatment of Diabetic Macular Edema

October 13, 2021

Video

Rishi P. Singh, MD, discusses new VISTA/VIVID data showing what really influences a patients' likelihood and time to DME resolution when treated with aflibercept.

Long-Term nAMD Patient Buy-In Is Still Lacking for Anti-VEGF Therapy

October 12, 2021

Video

Theodore Leng, MD, MS, defines the trends of patient discontinuation, and how direct caregivers may help to reduce risk of losing patients.

How Virtual Visits, Port Delivery System Therapy Can Benefit Retina Practices

October 12, 2021

Video

Arshad Khanani, MD, MA, explains how new measures made available to ophthalmology will help address a quickly growing patient population.

Anti-VEGF Continuation Wanes After 3-6 Years for Patients with nAMD

October 11, 2021

Video

Theodore Leng, MD, MS, discusses new findings based on IRIS registry data showing long-term discontinuation trends in patients.

FDA Approves Avacopan for ANCA Vasculitis

October 08, 2021

Article

The treatment is the first FDA approved orally-administered inhibitor of the complement C5a receptor.